YOU WERE LOOKING FOR :Pharmaceutical Industry Marketing Environment
Essays 91 - 120
In six pages this paper contemplates what 2035 would have held in store for the pharmaceutical industry had there been passage of ...
In eight pages this paper examines America's history of quackery and scams with the pharmaceuticals industry the primary focus. T...
the salespeople, not to mention the third-party vendors who might be involved with the manufacture and distribution of the product...
In thirty pages this report considers European and American approaches to pharmaceutical advertising in an examination of similari...
In twenty pages this paper examines SmithKline Beecham Pharmaceuticals in an overview of its financial performance and industry st...
In ten pages this paper discusses drug development and issues including research and birth control as they relate to the pharmaceu...
This twenty three page paper provides a detailed look at the conference proceedings and the complicated issues that emerged. Drug...
In forty pages this research study examines the international pharmaceutical industry in an overview of global acquisitions, merge...
than obligations to the government; second, "the distinction between therapeutic and nontherapeutic research is taken to have mora...
orchestrated our growing dependence on prescription drugs. Big Pharma now represents a practically inescapable component ...
18.5 percent profit margin, more than four times that of all other industries" (Barry, 2002, May). With that money the drug indust...
likely not endear the FDA to elderly people who at this point cannot afford medication and are forced to go over the border to pur...
demand and unemployment. When Ronald Reagan entered office, he initiated his famous "supply side" economic theory with its "trickl...
drug can work under "ideal" conditions rather than a real-world environment, tend to take place in controlled artificial environme...
to expand their capacity for research and basically, to increase their overall productivity (Borchardt, 2000). The analysis fram...
caused a greater demand for information, as well as product. That information is made available through the increased and strategi...
the cost and regardless of who pays for the care that individuals receive. Though grossly oversimplified, the skeletal structure ...
care issues will explore the relationship between European think tanks and the multinational pharmaceutical companies, specificall...
for the firm to start increasing the level of expenditure on research and development. To determine the most appropriate strategy ...
In fourteen pages this paper discusses the global pharmaceutical industry and the World Health Organization's efforts to combat va...
creates a document that addresses the extent to which the program is in compliance with the standards for accreditation published ...
notes that another five percent are victims of occasional despondency, with one of every six people succumbing to a "serious, or m...
is the best product, [healthcare providers] will just use a cheaper product, and then if it doesnt work, theyll go to your product...
grew from an average of seven in 1993 to an average of eleven in 2000 to an average of twelve in 2004 (Critser, 2007). At the tim...
just came on the market. This paper will demonstrate that this difficult career can be rewarding as it provides a worthwhile livin...
do, in fact, demonstrate an phenomenal increase over time in the number of prescriptions that the typical American uses. This num...
and it sells Zantac under the Warner-Lambert name, another acquisition (Hoovers, 2002). It was Warner-Lambert who manufactured Lip...
Patents cover such things as chemicals, "pharmaceutical formulations, methods of making chemicals and methods of treating patients...
or tested will never make it to market due to ineffective results, the development of side effects or other influencing criteria. ...
article provides a polite, superficial look at the problem. 4. This is a financial issue. IV. Conclusion This article should...